Beam Therapeutics Inc. – Filings and Transcripts

NASDAQ: BEAM
Share price (4/24/26): $27.11
Market cap (4/24/26): $2.785 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Cavanagh Bethany J

Bellon Christine

News Filter

Termination of Material Definitive Agreement

Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria

Material Definitive Agreement, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Sets Strategic Priorities for Its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs and Extends Its Operating Runway Through Commercial Transition

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC